Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2021

Open Access 01-12-2021 | Tuberculosis | Research article

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis

Authors: Yong Yang, Shaojun Zhang, Zhengwei Dong, Yong Xu, Xuefei Hu, Gening Jiang, Lin Fan, Liang Duan

Published in: Journal of Cardiothoracic Surgery | Issue 1/2021

Login to get access

Abstract

Objective

Surgical resection plays an essential role in the treatment of Pulmonary Tuberculosis (PTB). There are few reports comparing lobectomy and sublobectomy for pulmonary TB with cavity. To compare the advantages between lobectomy and sublobectomy for localized cavitory PTB, we performed a single-institution cross sectional cohort study of the surgical patients.

Methods

We consecutively included 203 patients undergoing lobectomy or sublobectomy surgery for localized cavitary PTB. All patients were followed up, recorded and compared their surgical complication, outcome and associated characteristics.

Results

Both groups had similar outcomes after follow up for 13.1 ± 12.1 months, however, sublobectomy group suffered fewer intraoperative blood losses, shorter length of stay, and fewer operative complications than lobectomy group (P <  0.05). Both groups obtained satisfactory outcome with postoperatively medicated for similar period of time and few relapse (P > 0.05).

Conclusion

Both sublobectomy and lobectomy resection were effective ways for cavitary PTB with surgical indications. If adequate anti-TB chemotherapy had been guaranteed, sublobectomy is able to be recommended due to more lung parenchyma retain, faster recover, and fewer postoperative complications.
Literature
2.
go back to reference Organization WH. Global tuberculosis report 2018. Geneva: WHO; 2018. Organization WH. Global tuberculosis report 2018. Geneva: WHO; 2018.
6.
go back to reference Rathman G, Sillah J, Hill PC, Murray JF, Adegbola R, Corrah T, Lienhardt C, McAdam KP. Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in the Gambia. Int J Tuberc Lung Dis. 2003;7(10):942–7.PubMed Rathman G, Sillah J, Hill PC, Murray JF, Adegbola R, Corrah T, Lienhardt C, McAdam KP. Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in the Gambia. Int J Tuberc Lung Dis. 2003;7(10):942–7.PubMed
8.
go back to reference Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, Lahart C, Metchock B, Pachucki C, Stanton L, Vernon A, Villarino ME, Wang YC, Weiner M, Weis S, Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360(9332):528–34. https://doi.org/10.1016/s0140-6736(02)09742-8.CrossRefPubMed Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, Lahart C, Metchock B, Pachucki C, Stanton L, Vernon A, Villarino ME, Wang YC, Weiner M, Weis S, Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet. 2002;360(9332):528–34. https://​doi.​org/​10.​1016/​s0140-6736(02)09742-8.CrossRefPubMed
10.
go back to reference Shah AM, Singhal P, Chhajed PN, Athavale A, Krishnan R, Shah AC. Bronchoscopic closure of bronchopleural fistula using gelfoam. J Assoc Physicians India. 2004;52:508–9.PubMed Shah AM, Singhal P, Chhajed PN, Athavale A, Krishnan R, Shah AC. Bronchoscopic closure of bronchopleural fistula using gelfoam. J Assoc Physicians India. 2004;52:508–9.PubMed
11.
go back to reference Organization WH. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: WHO; 2019. Organization WH. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: WHO; 2019.
12.
go back to reference Organization WH: Guidelines for treatment of tuberculosis; 2010. Organization WH: Guidelines for treatment of tuberculosis; 2010.
20.
go back to reference Kempker RR, Rabin AS, Nikolaishvili K, Kalandadze I, Gogishvili S, Blumberg HM, Vashakidze S. Additional drug resistance in mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clin Infect Dis. 2012;54(6):e51–4. https://doi.org/10.1093/cid/cir904.CrossRefPubMed Kempker RR, Rabin AS, Nikolaishvili K, Kalandadze I, Gogishvili S, Blumberg HM, Vashakidze S. Additional drug resistance in mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clin Infect Dis. 2012;54(6):e51–4. https://​doi.​org/​10.​1093/​cid/​cir904.CrossRefPubMed
22.
go back to reference Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WCM, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MID, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, van der Walt M, van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ, Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300. https://doi.org/10.1371/journal.pmed.1001300.CrossRefPubMedPubMedCentral Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WCM, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MID, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, van der Walt M, van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ, Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300. https://​doi.​org/​10.​1371/​journal.​pmed.​1001300.CrossRefPubMedPubMedCentral
Metadata
Title
Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
Authors
Yong Yang
Shaojun Zhang
Zhengwei Dong
Yong Xu
Xuefei Hu
Gening Jiang
Lin Fan
Liang Duan
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2021
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-021-01401-5

Other articles of this Issue 1/2021

Journal of Cardiothoracic Surgery 1/2021 Go to the issue